Sulfad

Sulfad is a phytopharmaceutical bioactive compound including CAF-6 & CAF-8 (main active ingredient 1,5 dicaffeoylquinic acid, also known as cynarine), Mariana90 (main active ingredient > 70% silibinin or (2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl]chroman-4-one), Glyc-6 (main active ingredient glycyrrhizinic acid or (3β,18α)-30-hydroxy-11,30-dioxoolean-12-en-3-yl 2-O-β-D-glucopyranuronosyl-β-D-glucopyranosiduronic acid), turmeric (main active ingredient C.I. 75300 or (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione).

Medicinal use
Sulfad is used in the management of different liver diseases including steatosis, steatohepatitis and viral hepatitis. It acts as potent antioxidant and hepatoprotective agent. Also it reduces triglycerides and LDL by different mechanisms.

Antioxidant effects
Oxidative stress is defined as structural and/or functional injury produced in tissues by the uncontrolled formation of pro-oxidant free radicals. Sulfad preserves the functional and structural integrity of hepatocyte membranes by preventing alterations of their phospholipid structure and by restoring alkaline phosphatase and gamma-glutamyl transpeptidase activities. Cynarine in Sulfad plays a major role in the prevention of oxidative damage to hepatocyte membranes.

Anti-inflammatory and anti-carcinogenic effects
Studies have shown that one of Sulfad's active constituents has a number of effects including inhibition of neutrophil migration, marked inhibition of leukotriene synthesis and formation of prostaglandins.

Liver regeneration
Sulfad produced a significant increase in the formation of ribosomes and in DNA synthesis, as well as an increase in protein synthesis. Interestingly, the increase in protein synthesis was induced by Sulfad only in injured livers, not in healthy controls.

As could be shown with isolated hepatocytes, Sulfad acts directly on the metabolism of the cell nucleus. Sulfad lead a normalization of the pathologically altered protein synthesis by increasing RNA synthesis. This improvement or normalization of the plasma protein picture, having been proven in several clinical studies.